Acumen Pharmaceuticals, Inc.ABOSNASDAQ

Revenue (LTM)

Net Income (LTM)

$-102M

-95.4% YoY

Free Cash Flow

$-86M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	1	0	0	0	0
Gross Profit	-7	-12↓87.5%	0	0	0
Operating Income	-8	-20↓147.5%	-45↓131.0%	-61↓35.2%	-114↓86.5%
Net Income	-7	-101↓1273.5%	-43↑57.4%	-52↓22.2%	-102↓95.4%
EBITDA	-8	-20↓147.5%	-43↓118.0%	-52↓20.9%	-98↓90.1%
EPS Diluted	-0.26	-2.63↓911.5%	-1.06↑59.7%	-1.08↓1.9%	-1.71↓58.3%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	44	122↑179.1%	130↑6.5%	67↓48.6%	36↓46.7%
Total Current Assets	44	199↑347.1%	180↓9.2%	247↑36.8%	178↓27.7%
Total Assets	44	230↑418.4%	197↓14.6%	310↑57.8%	239↓22.9%
Total Current Liabilities	6	5↓19.2%	8↑51.8%	13↑66.0%	28↑112.8%
Total Liabilities	63	5↓91.8%	8↑51.8%	43↑452.4%	57↑32.5%
Total Equity	-19	225↑1311.2%	189↓16.2%	267↑41.4%	182↓31.9%
Total Debt	0	0	0	28↑27030.5%	30↑4.3%
Net Debt	-44	-122↓179.1%	-130↓6.4%	-38↑70.5%	-6↑84.6%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-7	-18↓141.1%	-35↓95.7%	-43↓22.5%	-86↓100.2%
Capital Expenditure	0	-0	-0↓302.5%	-0↑87.0%	-0↑23.8%
Free Cash Flow	-7	-18↓141.6%	-35↓96.2%	-43↓22.0%	-86↓100.1%
Stock-Based Comp	0	1↑498.7%	3↑232.0%	6↑100.8%	10↑56.8%
Net Change in Cash	37	78↑110.6%	8↓89.9%	-63↓893.3%	-31↑50.4%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance